Pulm_Div_Dransfield

 

Associate Professor of Medicine

Medical Director, UAB Lung Health Center

Division of Pulmonary, Allergy & Critical Care Medicine
1720 2nd Avenue So, THT-422
University of Alabama at Birmingham
Birmingham, AL 35294

Board Certifications
2000, American Board of Internal Medicine
2002, 2012 American Board of Internal Medicine, Pulmonary Diseases
2003, 2013 American Board of Internal Medicine, Critical Care Medicine

Medical School: University of North Carolina School of Medicine,
Chapel Hill, North Carolina, 1997

Internship:  University of Alabama - Birmingham, 1997-1998

Residency:  University of Alabama - Birmingham, 1998-2000

Fellowship:  University of Alabama - Birmingham, 2000-2003

Chief Fellow:  University of Alabama - Birmingham, 2002-2003 

Contact Information

Campus Address:

 THT 422

Academic Office location:

 OHB 153

Office Phone:

 (205) 934-5425

Office Fax (Academic):

 (205) 934-3277

TKC Clinic Phone:

 (205) 801-7545

TKC Clinic Fax:

 (205) 802-8231

Email Address:

 mdrans99@uab.edu

Beeper #:

 5317

Office Assistant:   
Linda Johnson-Phipps                          
ljphipps@uab.edu                           
Ph: (205) 996-0101

Fax: (205) 934-3277

Brief Bio
Dr. Dransfield completed his medical degree at the University of North Carolina at Chapel Hill in 1997, followed by residency in internal medicine and fellowship training in pulmonary and critical care medicine at the University of Alabama at Birmingham, where he served as Chief Fellow.  He has been on the faculty at UAB since 2003 and is currently Associate Professor of Medicine in the Division of Pulmonary, Allergy and Critical Care Medicine.  He serves as the Medical Director of the UAB Lung Health Center and is also the Medical Director of Pulmonary Rehabilitation. Dr. Dransfield is also the Director of the Bronchoscopy unit and the Lung Mass Clinic at the Birmingham VA Medical Center.  He was named as a "Top 10 Teacher" in the Department of Medicine in 2006-2008, and in 2009 he was a recipient of the Cobbs-Rutsky Award for Clinical Excellence in Teaching.  He was named one of America's Top Doctors for 2010-2016.

Clinical Interests 
Dr. Dransfield's clinical interests include chronic obstructive pulmonary disease (COPD) and lung cancer. He has particular interest in the care of patients with advanced COPD and directs the UAB Centers for Medicare and Medicade Services Bundled Payments for Care Initiative for COPD. Dr. Dransfield also evaluates patients with suspected or confirmed thoracic malignancies.

Academic & Research Interests
Dr. Dransfield's primary research interests are Clinical Trials, Epidemiology and outcomes of COPD. He is Principal Investigator for multiple clinical trials at the UAB Lung Health Center including the NIH sponsored COPD Clinical Research Network studies and COPDGene as well as multiple phase II-IV pharma sponsored projects.  As Medical Director of the LHC he also oversees multiple translational research projects focusing on airways disease.  The LHC has the capability for all aspects of pulmonary function testing as well as research bronchoscopy and has active collaborations across campus for mass spectrometry and proteomics, synthetic chemistry, biospecimen analysis and storage, and murine physiology and sample analysis.

Key Publications
Iyer AS, Bhatt SP, Garner JJ, Wells JM, Trevor JL, Patel NM, Kirkpatrick D, Williams JC, Dransfield MT. Depression is Associated with Readmission Due To Acute Exacerbation Of Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2015 Nov 24. [Epub ahead of print] PMID: 26599286


Wells JM, Morrison JB, Bhatt SP, Nath H, Dransfield MT. Pulmonary artery enlargement is associated with cardiac injury during severe exacerbations of COPD. Chest. 2015 Oct 22. doi: 10.1378/chest.15-1504. [Epub ahead of print] PMID:26501747

Bhatt SP, Terry N, Nath H, Zach JA, Tschirren J, Bolding MS, Stinson DS, Wilson CG, Curran-Everett D, Lynch DA, Putcha N, Soler X, Wise RA, Washko GR, Hoffman EA, Foreman MG, Dransfield MT; COPDGene Study Investigators. Association Between Expiratory Central Airway Collapse and Respiratory Outcomes Among Smokers. JAMA; in press Dec 30 2015.

Bhatt SP, Wells JM, Kinney GL, Washko GR Jr, Budoff M, Kim YI, Bailey WC, Nath H, Hokanson JE, Silverman EK, Crapo J, Dransfield MT; COPDGene Investigators.β-Blockers are associated with a reduction in COPD exacerbations. Thorax. 2016 Jan;71(1):8-14. doi: 10.1136/thoraxjnl-2015-207251. Epub 2015 Aug 17. PMID: 26283710

Wells JM, Iyer AS, Rahaghi FN, Bhatt SP, Gupta H, Denney TS, Lloyd SG, Dell'Italia LJ, Nath H, Estepar RS, Washko GR, Dransfield MT. Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease. Circ Cardiovasc Imaging. 2015 Apr;8(4). pii: e002546. doi: 10.1161/CIRCIMAGING.114.002546. PMID:25855668

Wells JM, Jackson PL, Viera L, Bhatt SP, Gautney J, Handley G, King RW, Xu X, Gaggar A, Bailey WC, Dransfield MT, Blalock JE. A Randomized, Placebo-controlled Trial of Roflumilast on Proline-glycine-proline and Neutrophilic Inflammation in COPD. Am J Respir Crit Care Med. 2015 Oct 15;192(8):934-42. doi: 10.1164/rccm.201503-0543OC. Jul 7. [Epub ahead of print] PMID:26151090


Please click here for Dr. Dransfield's complete publications listing.

SOM Epilogue Menu